$7.26 +0.32 (4.62%)
Niagen Bioscience, Inc. Common Stock (NAGE)
Niagen Bioscience, Inc. is a biotechnology company focused on developing and commercializing nicotinamide riboside (NR), a form of vitamin B3 that supports cellular health and energy metabolism. The company aims to leverage its proprietary NAD+ booster to address various age-related health conditions and promote overall wellness.